Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada

@inproceedings{Champredon2018AssessingTB,
  title={Assessing the benefits of early pandemic influenza vaccine availability: a case study for Ontario, Canada},
  author={David Champredon and Marek Laskowski and Nathalie Charland and Seyed M. Moghadas},
  booktitle={Scientific Reports},
  year={2018}
}
New vaccine production technologies can significantly shorten the timelines for availability of a strain-specific vaccine in the event of an influenza pandemic. We sought to evaluate the potential benefits of early vaccination in reducing the clinical attack rate (CAR), taking into account the timing and speed of vaccination roll-out. Various scenarios corresponding to the transmissibility of a pandemic strain and vaccine prioritization strategies were simulated using an agent-based model of… CONTINUE READING
4
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES

The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines

Ward, J B.
  • Human Vaccines & Immunotherapeutics
  • 2017

Estimating the potential effects of a vaccine program against an emerging influenza pandemic--United States.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2015

European Journal of Pharmaceutics and Biopharmaceutics

P. C. Soema, R. Kompier, J.-P. Amorij, G. F. A. Kersten
  • European Journal of Pharmaceutics and Biopharmaceutics
  • 2015

Flu vaccination rates in Canada

L. Gionet
  • (Statistics Canada,
  • 2015